Altitude Sickness Prevention Online in Nevada (Acute Mountain Sickness Prophylaxis)

Yes, if you are an adult 18+ located in Nevada, planning travel to a moderate-altitude destination, and you do not have a sulfa allergy or other contraindications. TeleDirectMD can prescribe acetazolamide when clinically appropriate after a video visit evaluation. Acetazolamide is not a controlled substance.

The current CDC Yellow Book-recommended prophylaxis dose is 125 mg by mouth twice daily (BID). This is lower than the older 250 mg BID regimen but has been shown in clinical trials to be equally effective with fewer side effects. You start 1 day (24 hours) before ascent and continue for 2 days at your maximum altitude. The physician will confirm the appropriate dose during your visit based on your specific situation.

The most common side effects are paresthesia (tingling or numbness in the fingers, toes, and face), increased urination, and a flat or metallic taste in carbonated drinks. These are expected pharmacological effects and indicate the medication is active. Less common effects include transient mild myopia, fatigue, and gastrointestinal discomfort. Serious reactions are rare but include symptomatic electrolyte disturbances in those with kidney disease or those taking potassium-wasting diuretics. The primary contraindication is sulfonamide (sulfa) allergy.

No. Acetazolamide (Diamox) is not a controlled substance. It is a prescription carbonic anhydrase inhibitor that can be prescribed via telehealth. TeleDirectMD does not prescribe controlled substances, and acetazolamide is fully within our telehealth prescribing scope.

TeleDirectMD offers a self pay option starting at $79 for an adult video visit in Nevada. Insurance is not required. The prescription cost for acetazolamide (generic) at your pharmacy is separate. Based on GoodRx data verified 2026-06-13, acetazolamide generic pricing has been cited at approximately $6.68 to $20.29 for a typical 10-day course depending on pharmacy and coupon availability. Costs vary.

The CDC Yellow Book recommends acetazolamide prophylaxis for adults with a history of prior AMS, those making rapid ascents (flying directly to altitudes above 2,750 m), and those traveling to destinations above 3,000 m who cannot acclimatize gradually. Individuals with low AMS risk who can ascend slowly without prior history may not require medication. Your physician will review your specific itinerary and risk profile during the visit.

Acetazolamide is a sulfonamide-derived drug, and sulfonamide antibiotic allergy (e.g., allergy to Bactrim or trimethoprim-sulfamethoxazole) is its primary contraindication. If you have a documented sulfa antibiotic allergy, you should disclose this during your visit. Your physician will evaluate the nature of the allergy — the cross-reactivity between sulfonamide antibiotics and acetazolamide is a complex topic. In general, a known severe sulfa allergy (especially anaphylaxis or Stevens-Johnson syndrome) is a contraindication. Alternative prophylaxis approaches and acclimatization planning will be discussed.

You should avoid alcohol for at least the first 48 hours at altitude, regardless of acetazolamide use. Alcohol independently impairs the hypoxic ventilatory response — the body's primary mechanism for compensating for low oxygen at altitude — and worsens altitude-related sleep-disordered breathing, which is a key contributor to AMS. Alcohol also accelerates dehydration. Moderate alcohol consumption may be resumed after 48 to 72 hours if you are well-acclimatized and free of AMS symptoms.

No. Physical fitness does not protect against AMS. This is one of the most important and frequently misunderstood facts about altitude physiology. AMS is caused by hypobaric hypoxia, not by aerobic deconditioning. Elite athletes who ascend rapidly to altitude are at equal or greater risk than sedentary travelers who ascend slowly. Slow, graded ascent is the most reliable non-pharmacological protection against AMS, regardless of fitness level.

These are all moderate-altitude destinations with significant AMS risk for unacclimatized sea-level travelers. Cusco, Peru sits at approximately 3,400 m (11,200 ft). La Paz, Bolivia sits at approximately 3,600 m (11,800 ft). Breckenridge, Colorado sits at approximately 2,926 m (9,600 ft) with ski runs reaching above 3,900 m. Travelers flying directly to any of these destinations without prior acclimatization are at meaningful AMS risk, and many travelers to Cusco and La Paz in particular benefit from acetazolamide prophylaxis due to the altitude and rapid ascent profile of most international flights into these cities.

Acute Mountain Sickness (AMS) is the common form: headache plus fatigue, nausea, or sleep disturbance that typically resolves with rest at the same altitude. High Altitude Cerebral Edema (HACE) is a life-threatening progression of AMS involving brain swelling, presenting with confusion, ataxia, and altered consciousness — it requires immediate descent. High Altitude Pulmonary Edema (HAPE) is a separate, non-cardiogenic pulmonary edema presenting with dyspnea at rest, persistent cough, and extreme fatigue — it also requires immediate descent and is the most common cause of death from altitude illness. TeleDirectMD manages pre-travel AMS prophylaxis only; HACE and HAPE are emergencies requiring immediate descent and emergency services.

Book your visit at least 5 to 7 days before departure so that you have time to fill the acetazolamide prescription at your pharmacy. The medication needs to be started 1 day before ascent, not 1 day before you leave home — factor in travel time and any intermediate stops before reaching altitude. Same-day appointments are often available, but advance planning ensures a smooth pre-travel experience.

Yes. TeleDirectMD offers adult evaluations via video visits across multiple states where our physicians are licensed. You must be physically located in the state where you are requesting care at the time of your video visit.

Insurance is not required. If your plan is eligible, you may be able to use insurance. A self pay option is also available.

Cusco, Peru sits at approximately 3,400 meters (11,200 feet), and most international flights arrive directly at this altitude without any acclimatization period. The CDC Yellow Book identifies both prior AMS history and rapid ascent above 2,750 meters as primary indications for acetazolamide prophylaxis — Cusco meets both criteria for the vast majority of air travelers. Machu Picchu itself sits at approximately 2,430 meters, but travelers typically base themselves in Cusco (3,400 m) or Ollantaytambo (2,792 m) the night before, which means the relevant sleeping altitude remains above the AMS risk threshold. Acetazolamide 125 mg twice daily, started 24 hours before arriving in Cusco, is the evidence-based prophylaxis for unacclimatized adults flying directly to this destination. A pre-travel telehealth visit is appropriate for adults 18+ located in eligible states (excluding NY) who do not have a sulfa allergy and are not pregnant.

La Paz, Bolivia is one of the highest capital cities in the world, with the main city center sitting at approximately 3,600 meters (11,800 feet) and the adjacent city of El Alto at approximately 4,000 meters. Travelers flying into El Alto International Airport (4,061 m) arrive at extreme altitude without any acclimatization period. The AMS risk for unacclimatized sea-level travelers flying directly to La Paz is high — studies of similar altitudes report AMS rates of 25 to 50 percent in the first 24 to 48 hours. The CDC Yellow Book recommends acetazolamide prophylaxis for travelers to destinations above 3,000 meters, particularly those flying in without a gradual ascent profile. Because the El Alto airport approaches 4,000 meters, travelers should discuss their specific itinerary during a telehealth visit so the physician can assess whether the destination is appropriate for telehealth management or warrants referral to an in-person travel clinic for a full altitude medicine evaluation.

Bogotá, Colombia sits at approximately 2,600 meters (8,530 feet) above sea level, which is above the AMS risk threshold of 2,500 meters established by the CDC Yellow Book and Wilderness Medical Society guidelines. Most travelers do not develop significant AMS in Bogotá because the altitude is moderate, the city is large and urban with limited strenuous activity on arrival, and many travelers from nearby cities arrive with partial acclimatization. However, unacclimatized sea-level travelers — particularly those flying from low-altitude North American cities — may experience mild headache, fatigue, and sleep disturbance in the first 24 to 48 hours. Travelers with prior AMS history, those with underlying cardiopulmonary conditions, or those who will be immediately physically active (e.g., hiking tours departing from Bogotá) may benefit from acetazolamide prophylaxis. A pre-travel telehealth evaluation can assess your specific risk profile for the Bogotá altitude.

Colorado's high-altitude mountain towns present real AMS risk for sea-level travelers, particularly those flying into Denver International Airport (1,655 m) and driving directly to altitude on the same day. Leadville, Colorado is the highest incorporated city in the United States at approximately 3,094 meters (10,151 feet) — above the CDC Yellow Book threshold for significant AMS risk. Breckenridge sits at approximately 2,926 meters (9,600 feet) at town elevation, with ski terrain reaching above 3,900 meters. Aspen sits at approximately 2,438 meters (7,990 feet) at town level, with ski lifts accessing terrain above 3,660 meters, meaning sleeping at town elevation but skiing to higher daytime altitudes increases overall hypoxic exposure. The CDC Yellow Book recommends acetazolamide prophylaxis for adults with prior AMS history or rapid ascents to altitudes above 2,750 meters. Travelers to these Colorado destinations who fly from sea level and plan to ski or hike on arrival day are at meaningful AMS risk. A telehealth visit allows prescription of acetazolamide 125 mg twice daily starting 24 hours before reaching altitude.

Kilimanjaro (summit 5,895 m) and Everest Base Camp (5,364 m) are extreme-altitude destinations that exceed TeleDirectMD's telehealth prescribing scope. TeleDirectMD manages altitude sickness prevention for moderate-altitude destinations in the approximately 2,500 to 4,000 meter range. Kilimanjaro and EBC treks require in-person evaluation at a wilderness medicine or travel medicine clinic because: (1) the altitude is extreme and carries risk of HACE and HAPE that warrants full medical clearance; (2) these itineraries typically require emergency rescue medication kits including dexamethasone and nifedipine, which TeleDirectMD does not prescribe via telehealth; and (3) graded ascent planning, oxygen system guidance, and advanced acclimatization protocols are beyond the scope of a telehealth pre-travel visit. If you are planning Kilimanjaro or EBC, consult an in-person wilderness medicine or travel medicine specialist well in advance of your departure — at least 4 to 6 weeks before the trek.

The current CDC Yellow Book-recommended prophylaxis dose is 125 mg by mouth twice daily (BID), which represents a deliberate reduction from the older 250 mg BID regimen that was historically prescribed. Clinical trial data cited in the CDC Yellow Book and Wilderness Medical Society guidelines demonstrate that 125 mg BID is equally effective at preventing AMS while producing fewer side effects than the higher dose. The mechanism of acetazolamide — carbonic anhydrase inhibition — is active at the lower dose; the efficacy relationship is not purely linear, so doubling the dose does not double protection but does substantially increase side effects including paresthesia (tingling in fingers and toes), polyuria, and gastrointestinal upset. Most travel medicine prescribers now use 125 mg BID as the standard prophylaxis dose. The 250 mg BID dose may appear in older references or be recommended by some specialists for high-risk individuals, but it is not the current CDC standard for prophylaxis.

Acetazolamide and dexamethasone serve fundamentally different roles in altitude medicine and are not interchangeable. Acetazolamide (Diamox) is the only FDA-approved medication for AMS prevention (prophylaxis). It works by stimulating ventilation through carbonic anhydrase inhibition, which accelerates the physiological acclimatization process. It is started before ascent and continued for 2 days at maximum altitude. Dexamethasone is a corticosteroid used for emergency rescue treatment of High Altitude Cerebral Edema (HACE) — a life-threatening complication of uncontrolled AMS. It does not cause acclimatization; it reduces cerebral edema temporarily to buy time for descent. Using dexamethasone as a routine prophylaxis agent is not recommended because it can mask AMS symptoms while allowing the underlying condition to progress. Dexamethasone is not prescribed by TeleDirectMD — it requires in-person prescribing as part of an emergency rescue kit for expedition-altitude travel above 4,000 meters and is outside the scope of telehealth pre-travel consultation.

This depends on your itinerary, destination altitude, ascent rate, and prior AMS history. Gradual acclimatization — gaining no more than 300 to 500 meters of sleeping altitude per day above 2,500 meters — is the non-pharmacological gold standard for AMS prevention and is recommended for all travelers regardless of medication use. However, many common travel itineraries do not permit gradual ascent: travelers flying directly to Cusco (3,400 m), La Paz (3,600 m), or arriving at Breckenridge from sea level on the same day have no acclimatization period. For these rapid-ascent itineraries, the CDC Yellow Book recommends acetazolamide prophylaxis. The two approaches are complementary, not mutually exclusive — most travelers benefit from both acetazolamide and building in acclimatization rest days on arrival. Travelers with prior AMS history reliably benefit from acetazolamide regardless of ascent rate, because their individual susceptibility means even moderate ascent rates can trigger symptoms. A telehealth visit reviews your specific itinerary to determine whether pharmacological prophylaxis is warranted.